Mead Johnson Nutrition Company

Bristol-Myers Squibb Compnay

Mjn U.S. Holdings LLC

Deborah A Schade

Kristin Morris

Robert J McMahon

Gyan P Rai

Francisco J Rosales

Eric Van Tol

Donald Carey Walker

Dirk Hondmann

Zeina Jouni

Dattatreya Banavara

Robert J Mcmahon

Zeina E Jouni

John D Alvey

Nagendra Rangavajla

Juan M Gonzalez

William Michael Russell

Win-Chin Chiang

James W Hansen

Yung-Hsiung Lee

Carol Lynn Berseth

Deshanie Rai

Hugh N Tucker

Joaquin Franco

Zeina E Joani

Kelly R Walsh

Dattatreya Banavera

Karen H Knauff

Kevin A Sims

Kelly Walsh

Ana Cecilia Munoz-Espada

A nutritional composition for improving the immunological function of a subject, including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which has a fermentation rate which is demonstrably slower than that of galacto-oligosaccharide.

Nutritional composition to promote healthy development and growth

A nutritional composition having a lipid or fat; a protein source; a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and up to about 2.5% by weight of a source of supplemental calcium which, when dissociated, provides a cation having prebiotic functionality.

The present disclosure provides compositions and methods for delivering nutrients to subjects requiring small-volume nutritional support, such as preterm infants. The compositions may comprise an emulsion of docosahexaenoic acid (DHA) and arachidonic acid (ARA). The nutritional compositions are useful, for example, in correcting nutritional deficiencies by increasing a subject's intake of nutrients, such as &#x3c9;-3 or &#x3c9;-6 long-chain polyunsaturated acids. The nutritional compositions are suitable for enteral delivery as a nutritional supplement or for oral delivery as a human milk or infant formula fortifier.

Compositions and methods for nutrient delivery

A nutritional formula which includes a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which comprises galacto-oligosaccharide; and about 0.015 to about 0.1 (pg/&#x3bc;g) ppm of TGF-&#x3b2;.

A nutritional composition including a lipid or fat; a protein source; at least about 5 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and at least about 0.2 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises a plurality of oligosaccharides such that the overall fermentation rate profile of the prebiotic composition provides an increased population of beneficial bacteria in the human gut over an extended period of time.

The present invention is directed an improved nutritional composition, methods of improving digestion, and methods of enhancing the bioavailability of TGF-&#x3b2;.

Nutritional composition with improved digestibility

A method for reducing the incidence of Intraventricular Hemorrhage in preterm infants, involving the administration to those infants of a combination of docosahexaenoic acid and arachidonic acid.

Method to reduce the incidence of intraventricular hemorrhage in preterm infants

Growing community of inventors

Evansville, IN, United States of America

Deborah A Schade